In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | -100% |
2015 | -$5.34 M | -1114.9% |
2014 | $0.52 M | -16.85% |
2013 | $0.63 M | 31.28% |
2012 | $0.48 M | 32022.8% |
2011 | $0 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | N/A | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $9.28 B | N/A | ๐บ๐ธ USA |
LabCorp LH | $12.90 B | N/A | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | $0.22 B | N/A | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.59 B | N/A | ๐บ๐ธ USA |
Enzo Biochem ENZ | $12.8 M | N/A | ๐บ๐ธ USA |